StonvexLoading…
StonvexStonvexStonvexCore line items from AKA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $600.21M | $574.70M | $546.26M | $611.74M |
Operating Income | $-18.05M | $-10.32M | $-83.41M | $-172.04M |
Net Income | $-31.43M | $-25.99M | $-98.89M | $-176.70M |
EPS (Diluted) | $-2.93 | $-2.46 | $-9.24 | $-16.47 |
Total Assets | $397.38M | $385.20M | $361.72M | $509.64M |
Total Liabilities | $299.61M | $267.57M | $213.10M | $262.56M |
Cash & Equivalents | $20.27M | $24.19M | $21.86M | $46.32M |
Free Cash Flow OCF − CapEx | $-633.00K | $-10.92M | $27.46M | $-20.07M |
Shares Outstanding | 10.77M | 10.67M | 10.57M | 10.75M |